大会即将到来！今年的ASCO会议上, 中山大学肿瘤防治中心共有13篇研究入选，下面快跟随小编来看看吧！
Poster Discussion
标题：Apatinib, a novel VEGFR inhibitor, combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer: A single-arm, open-label, phase 2 study.
时间：6月4号，4:54 PM - 6:00 PM
地点：S100bc
Poster Board
徐瑞华
标题：Subgroup analysis by prior anti-VEGF or anti-EGFR target therapy in FRESCO, a randomized, double-blind, phase 3 trial comparing fruquintinib versus placebo plus best supportive care in Chinese patients with metastatic colorectal cancer (mCRC).
标题： A phase I study of a novel IAP inhibitor APG-1387 in patients with advanced solid tumors.
林桐榆
标题：A proposal for a new staging system for extranodal natural
killer T-cell lymphoma, nasal type, to predict the treatment strategy: A multicentre study from the Chinese Southwest Oncology Group and Asia Lymphoma Study Group.
标题：Lenalidomide with R-IMED (rituximab, ifosfamide,methotrexate, etoposide and dexamethasone) in refractory or relapsed non-GCB diffuse large B-cell lymphoma: A phase II clinical trial.
黄河
标题：Randomized, open-label, phase Ⅱ trial of everolimus versus thalidomide in patients achieving remission after first-line therapy for high-risk diffuse large B-cell lymphoma.
标题：Comparison of different adjuvant therapy after radical surgery in early stage cervical carcinoma: A 3-arm randomized control study.
何文卓
标题：Comparison of mismatch repair status between primary and matched metastatic sites in patients with colorectal cancer.
李志铭
标题：A phase II trial of bevacizumab-GemAOD regimen for newly diagnosed extranodal NK/T cell lymphoma.
赵洪云
标题：A multicenter, randomized, double-blind, placebo-controlledphase III study of apatinib or placebo plus gefitinib as first-line treatment in patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC).
王 峰
标题：Trastuzumab plus docetaxel and capecitabine for first-line treatment of Her2-positive advanced gastric cancer: A phase II, multi-center, open-label, single-arm study.
李德兰
标题：Genetic aberrations related to increased risks of brain metastasis in non-small cell lung cancer (GASTO-1036).
Kuiyuan Liu
标题：Comparison between lobaplatin and cisplatin plus 5-fluorouracil combined with intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma: A multicenter randomized phase III clinical trial.
以上如有遗漏，请给我们留言！！！
苏公网安备32059002004080号
